150482-72-7 Usage
Uses
Used in Organic Synthesis:
(R)-3-AMINO-2(BENZYLAMINO)PROPAN-1-OL is used as a building block in organic synthesis for the creation of various functionalized compounds. Its unique structure allows for the development of a wide range of molecules with different properties and applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (R)-3-AMINO-2(BENZYLAMINO)PROPAN-1-OL is used as a key component in the development of new drugs. Its potential biological activities and therapeutic applications make it a valuable asset in the search for novel treatments for various medical conditions.
Used in Drug Development:
(R)-3-AMINO-2(BENZYLAMINO)PROPAN-1-OL is also utilized in drug development due to its potential for forming compounds with therapeutic properties. Researchers are exploring its use in creating new medications that could address unmet medical needs and improve patient outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 150482-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,4,8 and 2 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 150482-72:
(8*1)+(7*5)+(6*0)+(5*4)+(4*8)+(3*2)+(2*7)+(1*2)=117
117 % 10 = 7
So 150482-72-7 is a valid CAS Registry Number.
150482-72-7Relevant academic research and scientific papers
Synthesis of Tetrahydropteridine C6-Stereoisomers, Including N5-Formyl-(6S)-tetrahydrofolic Acid
Bailey, Steven W.,Chandrasekaran, Rama Y.,Ayling, June E.
, p. 4470 - 4477 (2007/10/02)
Chiral N1-protected vicinal diamines derived from amino acids were condensed with 2-amino-6-chloro-5-nitro-4(3H)-pyrimidinone, the nitro group reduced, and the amine deprotected.Oxidative cyclization of the resulting triaminopyrimidinone via quinoid pyrimidine intermediates gave a quinoid dihydropteridine, which was then reduced to a tetrahydropteridine C6-stereoisomer.Thus, 6(R)- and 6(S)-propyltetrahydropterin were stereospecifically synthesized (99 percent enantiomeric purity) in good yield from D- and L-norvaline, respectively.Reductive alkylation of (p-aminobenzoyl)-L-glutamate with a niropyrimidine aldehyde derived from D- or L-serine similarly afforded, after cyclization and reduction, (6R)- or (6S)-tetrahydrofolic acid.The latter was then converted to the natural isomer of leucovorin by regioselective N5-formylation with carbonyl diimidazole / formic acid without loss of enantiomeric purity.
